Industry Research Reports

Home > Reports > Pharma & Healthcare > Heparin (Heparin Sodium and Heparin Calcium) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Heparin (Heparin Sodium and Heparin Calcium) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 133 Pages

Report ld: 2337244

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.

Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

Heparin (Heparin Sodium and Heparin Calcium) Market Size

M= millions and B=billions

This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

The global market for Heparin (Heparin Sodium and Heparin Calcium) was estimated to be worth US$ 2632.1 million in 2023 and is forecast to a readjusted size of US$ 6113.5 million by 2030 with a CAGR of 12.5% during the forecast period 2024-2030
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc.

In recent years, with the impact of African swine fever and the outbreak of COVID-19. Heparin as a resource-based industry expected to be in a state of tight supply for a period in the future, and the tight supply state may drive the sales price of heparin products to rise, the future driving force of the industry is more obvious, and the long-term profitability is more certain. The price of heparin has ushered in a major upward cycle since 2016. The main reason is that China is the main supplier of live pigs in the world. The raging African swine fever has greatly reduced the supply of live pigs, driving the price of heparin to rise sharply.

Asia-Pacific is the largest consumption place, with a revenue market share nearly 35% in 2022. Mainly China is the worlds’ largest pig production, which supplied by sufficient raw materials. Following Asia-Pacific, Europe is the second largest consumption place with the revenue market share nearly 34%.
The global key manufacturers of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and etc. In 2022, the global top five players hold a share approximately 57% in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Heparin (Heparin Sodium and Heparin Calcium), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heparin (Heparin Sodium and Heparin Calcium) by region & country, by Type, and by Application.

The Heparin (Heparin Sodium and Heparin Calcium) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin (Heparin Sodium and Heparin Calcium).

Market Segmentation

Report Metric
Details
Report Title
Heparin (Heparin Sodium and Heparin Calcium) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 6113.5 million
CAGR(2024-2030)
12.5%
Market Size Available for Years
2019-2030
Global Heparin (Heparin Sodium and Heparin Calcium) Companies Covered
Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, Dongying Tiandong Pharmaceutical, Opocrin, Hubei Enoray Biopharmaceutical, Yino Pharma, Cisen Pharmaceutical, Nanjing Xinbai Pharmaceutical, Sichuan Deebio Pharmaceutical
Global Heparin (Heparin Sodium and Heparin Calcium) Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Heparin (Heparin Sodium and Heparin Calcium) Market, Segment by Type
Heparin Sodium

Heparin Calcium
Global Heparin (Heparin Sodium and Heparin Calcium) Market, Segment by Application
UFH

LMWH
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Heparin (Heparin Sodium and Heparin Calcium) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Heparin (Heparin Sodium and Heparin Calcium) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Heparin (Heparin Sodium and Heparin Calcium) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Heparin (Heparin Sodium and Heparin Calcium) Product Introduction
    1.2 Global Heparin (Heparin Sodium and Heparin Calcium) Market Size Forecast
        1.2.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value (2019-2030)
        1.2.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume (2019-2030)
        1.2.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Price (2019-2030)
    1.3 Heparin (Heparin Sodium and Heparin Calcium) Market Trends & Drivers
        1.3.1 Heparin (Heparin Sodium and Heparin Calcium) Industry Trends
        1.3.2 Heparin (Heparin Sodium and Heparin Calcium) Market Drivers & Opportunity
        1.3.3 Heparin (Heparin Sodium and Heparin Calcium) Market Challenges
        1.3.4 Heparin (Heparin Sodium and Heparin Calcium) Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Heparin (Heparin Sodium and Heparin Calcium) Players Revenue Ranking (2023)
    2.2 Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Company (2019-2024)
    2.3 Global Heparin (Heparin Sodium and Heparin Calcium) Players Sales Volume Ranking (2023)
    2.4 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Company Players (2019-2024)
    2.5 Global Heparin (Heparin Sodium and Heparin Calcium) Average Price by Company (2019-2024)
    2.6 Key Manufacturers Heparin (Heparin Sodium and Heparin Calcium) Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Heparin (Heparin Sodium and Heparin Calcium) Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Heparin (Heparin Sodium and Heparin Calcium)
    2.9 Heparin (Heparin Sodium and Heparin Calcium) Market Competitive Analysis
        2.9.1 Heparin (Heparin Sodium and Heparin Calcium) Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Heparin (Heparin Sodium and Heparin Calcium) Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin (Heparin Sodium and Heparin Calcium) as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Heparin Sodium
        3.1.2 Heparin Calcium
    3.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type
        3.2.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value, by Type (2019-2030)
        3.2.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value, by Type (%) (2019-2030)
    3.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Type
        3.3.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume, by Type (2019-2030)
        3.3.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume, by Type (%) (2019-2030)
    3.4 Global Heparin (Heparin Sodium and Heparin Calcium) Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 UFH
        4.1.2 LMWH
    4.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application
        4.2.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value, by Application (2019-2030)
        4.2.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value, by Application (%) (2019-2030)
    4.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Application
        4.3.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume, by Application (2019-2030)
        4.3.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume, by Application (%) (2019-2030)
    4.4 Global Heparin (Heparin Sodium and Heparin Calcium) Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Region
        5.1.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Region (2019-2024)
        5.1.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Region (2025-2030)
        5.1.4 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Region (%), (2019-2030)
    5.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Region
        5.2.1 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Region (2019-2024)
        5.2.3 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Region (2025-2030)
        5.2.4 Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Region (%), (2019-2030)
    5.3 Global Heparin (Heparin Sodium and Heparin Calcium) Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        5.4.2 North America Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        5.5.2 Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        5.6.2 Asia Pacific Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        5.7.2 South America Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        5.8.2 Middle East & Africa Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Value
        6.2.1 Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        6.3.2 United States Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        6.4.2 Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        6.5.2 China Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        6.6.2 Japan Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        6.7.2 South Korea Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        6.8.2 Southeast Asia Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019-2030
        6.9.2 India Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Shenzhen Hepalink Pharmaceutical
        7.1.1 Shenzhen Hepalink Pharmaceutical Company Information
        7.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
        7.1.3 Shenzhen Hepalink Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Shenzhen Hepalink Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.1.5 Shenzhen Hepalink Pharmaceutical Recent Development
    7.2 Yantai Dongcheng Pharmaceutical
        7.2.1 Yantai Dongcheng Pharmaceutical Company Information
        7.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview
        7.2.3 Yantai Dongcheng Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Yantai Dongcheng Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.2.5 Yantai Dongcheng Pharmaceutical Recent Development
    7.3 Nanjing King-friend Biochemical Pharmaceutical
        7.3.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
        7.3.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
        7.3.3 Nanjing King-friend Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Nanjing King-friend Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.3.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development
    7.4 Pfizer
        7.4.1 Pfizer Company Information
        7.4.2 Pfizer Introduction and Business Overview
        7.4.3 Pfizer Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Pfizer Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.4.5 Pfizer Recent Development
    7.5 Hebei Changshan Biochemical Pharmaceutical
        7.5.1 Hebei Changshan Biochemical Pharmaceutical Company Information
        7.5.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
        7.5.3 Hebei Changshan Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Hebei Changshan Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.5.5 Hebei Changshan Biochemical Pharmaceutical Recent Development
    7.6 Bioibérica
        7.6.1 Bioibérica Company Information
        7.6.2 Bioibérica Introduction and Business Overview
        7.6.3 Bioibérica Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Bioibérica Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.6.5 Bioibérica Recent Development
    7.7 Qingdao Jiulong Biopharmaceutical
        7.7.1 Qingdao Jiulong Biopharmaceutical Company Information
        7.7.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
        7.7.3 Qingdao Jiulong Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Qingdao Jiulong Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.7.5 Qingdao Jiulong Biopharmaceutical Recent Development
    7.8 Changzhou Qianhong Biopharma
        7.8.1 Changzhou Qianhong Biopharma Company Information
        7.8.2 Changzhou Qianhong Biopharma Introduction and Business Overview
        7.8.3 Changzhou Qianhong Biopharma Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Changzhou Qianhong Biopharma Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.8.5 Changzhou Qianhong Biopharma Recent Development
    7.9 Dongying Tiandong Pharmaceutical
        7.9.1 Dongying Tiandong Pharmaceutical Company Information
        7.9.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview
        7.9.3 Dongying Tiandong Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Dongying Tiandong Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.9.5 Dongying Tiandong Pharmaceutical Recent Development
    7.10 Opocrin
        7.10.1 Opocrin Company Information
        7.10.2 Opocrin Introduction and Business Overview
        7.10.3 Opocrin Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Opocrin Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.10.5 Opocrin Recent Development
    7.11 Hubei Enoray Biopharmaceutical
        7.11.1 Hubei Enoray Biopharmaceutical Company Information
        7.11.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview
        7.11.3 Hubei Enoray Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Hubei Enoray Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.11.5 Hubei Enoray Biopharmaceutical Recent Development
    7.12 Yino Pharma
        7.12.1 Yino Pharma Company Information
        7.12.2 Yino Pharma Introduction and Business Overview
        7.12.3 Yino Pharma Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Yino Pharma Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.12.5 Yino Pharma Recent Development
    7.13 Cisen Pharmaceutical
        7.13.1 Cisen Pharmaceutical Company Information
        7.13.2 Cisen Pharmaceutical Introduction and Business Overview
        7.13.3 Cisen Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Cisen Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.13.5 Cisen Pharmaceutical Recent Development
    7.14 Nanjing Xinbai Pharmaceutical
        7.14.1 Nanjing Xinbai Pharmaceutical Company Information
        7.14.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview
        7.14.3 Nanjing Xinbai Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Nanjing Xinbai Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.14.5 Nanjing Xinbai Pharmaceutical Recent Development
    7.15 Sichuan Deebio Pharmaceutical
        7.15.1 Sichuan Deebio Pharmaceutical Company Information
        7.15.2 Sichuan Deebio Pharmaceutical Introduction and Business Overview
        7.15.3 Sichuan Deebio Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Sichuan Deebio Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
        7.15.5 Sichuan Deebio Pharmaceutical Recent Development

 8 Industry Chain Analysis
    8.1 Heparin (Heparin Sodium and Heparin Calcium) Industrial Chain
    8.2 Heparin (Heparin Sodium and Heparin Calcium) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Heparin (Heparin Sodium and Heparin Calcium) Sales Model
        8.5.2 Sales Channel
        8.5.3 Heparin (Heparin Sodium and Heparin Calcium) Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Heparin (Heparin Sodium and Heparin Calcium) Market Trends
    Table 2. Heparin (Heparin Sodium and Heparin Calcium) Market Drivers & Opportunity
    Table 3. Heparin (Heparin Sodium and Heparin Calcium) Market Challenges
    Table 4. Heparin (Heparin Sodium and Heparin Calcium) Market Restraints
    Table 5. Global Heparin (Heparin Sodium and Heparin Calcium) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Heparin (Heparin Sodium and Heparin Calcium) Revenue Market Share by Company (2019-2024)
    Table 7. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Heparin (Heparin Sodium and Heparin Calcium) Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Heparin (Heparin Sodium and Heparin Calcium) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Heparin (Heparin Sodium and Heparin Calcium) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Heparin (Heparin Sodium and Heparin Calcium)
    Table 13. Global Heparin (Heparin Sodium and Heparin Calcium) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin (Heparin Sodium and Heparin Calcium) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Heparin (Heparin Sodium and Heparin Calcium) Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Heparin (Heparin Sodium and Heparin Calcium) Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Heparin (Heparin Sodium and Heparin Calcium) Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Heparin (Heparin Sodium and Heparin Calcium) Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Heparin (Heparin Sodium and Heparin Calcium) Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Heparin (Heparin Sodium and Heparin Calcium) Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Volume, (2025-2030) & (K MT)
    Table 57. Shenzhen Hepalink Pharmaceutical Company Information
    Table 58. Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
    Table 59. Shenzhen Hepalink Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. Shenzhen Hepalink Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 61. Shenzhen Hepalink Pharmaceutical Recent Development
    Table 62. Yantai Dongcheng Pharmaceutical Company Information
    Table 63. Yantai Dongcheng Pharmaceutical Introduction and Business Overview
    Table 64. Yantai Dongcheng Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. Yantai Dongcheng Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 66. Yantai Dongcheng Pharmaceutical Recent Development
    Table 67. Nanjing King-friend Biochemical Pharmaceutical Company Information
    Table 68. Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
    Table 69. Nanjing King-friend Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. Nanjing King-friend Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 71. Nanjing King-friend Biochemical Pharmaceutical Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Pfizer Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. Hebei Changshan Biochemical Pharmaceutical Company Information
    Table 78. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
    Table 79. Hebei Changshan Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Hebei Changshan Biochemical Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 81. Hebei Changshan Biochemical Pharmaceutical Recent Development
    Table 82. Bioibérica Company Information
    Table 83. Bioibérica Introduction and Business Overview
    Table 84. Bioibérica Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. Bioibérica Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 86. Bioibérica Recent Development
    Table 87. Qingdao Jiulong Biopharmaceutical Company Information
    Table 88. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
    Table 89. Qingdao Jiulong Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 90. Qingdao Jiulong Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 91. Qingdao Jiulong Biopharmaceutical Recent Development
    Table 92. Changzhou Qianhong Biopharma Company Information
    Table 93. Changzhou Qianhong Biopharma Introduction and Business Overview
    Table 94. Changzhou Qianhong Biopharma Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 95. Changzhou Qianhong Biopharma Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 96. Changzhou Qianhong Biopharma Recent Development
    Table 97. Dongying Tiandong Pharmaceutical Company Information
    Table 98. Dongying Tiandong Pharmaceutical Introduction and Business Overview
    Table 99. Dongying Tiandong Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 100. Dongying Tiandong Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 101. Dongying Tiandong Pharmaceutical Recent Development
    Table 102. Opocrin Company Information
    Table 103. Opocrin Introduction and Business Overview
    Table 104. Opocrin Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 105. Opocrin Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 106. Opocrin Recent Development
    Table 107. Hubei Enoray Biopharmaceutical Company Information
    Table 108. Hubei Enoray Biopharmaceutical Introduction and Business Overview
    Table 109. Hubei Enoray Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 110. Hubei Enoray Biopharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 111. Hubei Enoray Biopharmaceutical Recent Development
    Table 112. Yino Pharma Company Information
    Table 113. Yino Pharma Introduction and Business Overview
    Table 114. Yino Pharma Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. Yino Pharma Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 116. Yino Pharma Recent Development
    Table 117. Cisen Pharmaceutical Company Information
    Table 118. Cisen Pharmaceutical Introduction and Business Overview
    Table 119. Cisen Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 120. Cisen Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 121. Cisen Pharmaceutical Recent Development
    Table 122. Nanjing Xinbai Pharmaceutical Company Information
    Table 123. Nanjing Xinbai Pharmaceutical Introduction and Business Overview
    Table 124. Nanjing Xinbai Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 125. Nanjing Xinbai Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 126. Nanjing Xinbai Pharmaceutical Recent Development
    Table 127. Sichuan Deebio Pharmaceutical Company Information
    Table 128. Sichuan Deebio Pharmaceutical Introduction and Business Overview
    Table 129. Sichuan Deebio Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 130. Sichuan Deebio Pharmaceutical Heparin (Heparin Sodium and Heparin Calcium) Product Offerings
    Table 131. Sichuan Deebio Pharmaceutical Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Heparin (Heparin Sodium and Heparin Calcium) Downstream Customers
    Table 135. Heparin (Heparin Sodium and Heparin Calcium) Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Heparin (Heparin Sodium and Heparin Calcium) Product Picture
    Figure 2. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Price (2019-2030) & (USD/MT)
    Figure 6. Heparin (Heparin Sodium and Heparin Calcium) Report Years Considered
    Figure 7. Global Heparin (Heparin Sodium and Heparin Calcium) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Heparin (Heparin Sodium and Heparin Calcium) Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin (Heparin Sodium and Heparin Calcium) Revenue in 2023
    Figure 10. Heparin (Heparin Sodium and Heparin Calcium) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Heparin Sodium Picture
    Figure 12. Heparin Calcium Picture
    Figure 13. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 16. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Heparin (Heparin Sodium and Heparin Calcium) Price by Type (2019-2030) & (USD/MT)
    Figure 18. Product Picture of UFH
    Figure 19. Product Picture of LMWH
    Figure 20. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 23. Global Heparin (Heparin Sodium and Heparin Calcium) Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Heparin (Heparin Sodium and Heparin Calcium) Price by Application (2019-2030) & (USD/MT)
    Figure 25. North America Heparin (Heparin Sodium and Heparin Calcium) Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Heparin (Heparin Sodium and Heparin Calcium) Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Heparin (Heparin Sodium and Heparin Calcium) Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Heparin (Heparin Sodium and Heparin Calcium) Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Heparin (Heparin Sodium and Heparin Calcium) Sales Volume (%), (2019-2030)
    Figure 37. United States Heparin (Heparin Sodium and Heparin Calcium) Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Heparin (Heparin Sodium and Heparin Calcium) Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Heparin (Heparin Sodium and Heparin Calcium) Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Heparin (Heparin Sodium and Heparin Calcium) Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Heparin (Heparin Sodium and Heparin Calcium) Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Heparin (Heparin Sodium and Heparin Calcium) Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Heparin (Heparin Sodium and Heparin Calcium) Sales Value by Application (%), 2023 VS 2030
    Figure 58. Heparin (Heparin Sodium and Heparin Calcium) Industrial Chain
    Figure 59. Heparin (Heparin Sodium and Heparin Calcium) Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.

Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 133 Pages

Report ld: 2337244

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License